Next Gen Biotech

Rexigo 120mg Tablet contains Relugolix, a medicine used to treat adult men with advanced hormone-sensitive prostate cancer. It belongs to a group of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists, which work by reducing the levels of testosterone, a hormone that fuels the growth of prostate cancer cells.

By lowering testosterone production, Rexigo 120mg helps slow down or stop the spread of prostate cancer. This can also reduce symptoms such as difficulty in urination or pain associated with the disease. The treatment is taken orally and offers an alternative to injections or surgical options used for testosterone suppression.